Thermo Fisher Scientific (TMO) Tops Q2 EPS by 25c; Raises guidance
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $464.61 +0.63%
Revenue Growth %: +7.9%
Financial Fact:
Restructuring and other costs, net: 54.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +7.9%
Financial Fact:
Restructuring and other costs, net: 54.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.37, $0.25 better than the analyst estimate of $5.12. Revenue for the quarter came in at $10.54 billion versus the consensus estimate of $10.5 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2024 EPS of $21.29-$22.07, versus the consensus of $21.70. Thermo Fisher Scientific sees FY2024 revenue of $42.4-43.3 billion, versus the consensus of $42.96 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
- Huntington Ingalls wins $418M Navy contract
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
